Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol

Autor:	Reid Jessica L., Kanhere Harsh A., Hewett Peter J., Price Timothy J., Maddern Guy J., Trochsler Markus I.
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	gastric pipac proof of concept Medicine Specialties of internal medicine RC581-951
Zdroj:	Pleura and Peritoneum, Vol 6, Iss 4, Pp 151-154 (2021)
Druh dokumentu:	article
ISSN:	2364-768X 2021-0132
DOI:	10.1515/pp-2021-0132
Popis:	Gastric cancer remains one of the most fatal cancers, despite an intensive treatment regime of chemotherapy–surgery–chemotherapy. Peritoneal metastatic disease is commonly diagnosed post treatment regime and once established, patients are likely to die in 3–9 months. Systemic chemotherapy does not increase survival for these patients due to the poor vascularisation of this area. We are proposing the addition of pressurised intraperitoneal aerosol chemotherapy (PIPAC) to the treatment regime for curative patients as a preventive measure to reduce the risk of peritoneal metastases occurring.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/361853aad73e4594872367fe284f9a78 Zobrazit plný text záznamu View record in DOAJ